Phytopharm plc Stock London S.E.
Equities
GB0006869720
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
05-23 | IXICO plc Signs Contract with Global Alzheimer's Platform Foundation to Support Bio-Hermes 2 Trial | CI |
05-21 | Earnings Flash (IXI.L) IXICO Posts Fiscal H1 Revenue GBP2.5M | MT |
Sales 2024 * | 5.2M 6.64M 9.05M | Sales 2025 * | - | Capitalization | 3.38M 4.32M 5.89M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.56M -3.48M | Net income 2025 * | - | EV / Sales 2024 * | 0.38 x |
Net cash position 2024 * | 1.4M 1.79M 2.44M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.17% |
Latest transcript on Phytopharm plc
Managers | Title | Age | Since |
---|---|---|---|
Giulio Cerroni
CEO | Chief Executive Officer | 63 | 17-02-05 |
Director of Finance/CFO | 47 | 19-05-30 | |
Charles Spicer
CHM | Chairman | 59 | 13-10-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 13-10-13 |
Director/Board Member | 49 | 16-09-15 | |
Dipti Amin
BRD | Director/Board Member | 60 | 23-10-04 |
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.98% | 40.47B | |
-10.87% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |